|
|
Clinical Observation of Infection Index in Patients With Pulmonary Infection and Fever Treated With Doxycycline |
Shao Jingtian1, Huang Yan2, Huang Lixian1 |
1. Three Departments of Enping Branch,Wuyi Hospital of Traditional Chinese Medicine,Jiangmen 529400,China; 2. Department of Critical Care Medicine,Wuyi Hospital of traditional Chinese medicine,Jiangmen 529400,China |
|
|
Abstract Objective To investigate the effect of doxycycline on the improvement of infection index in patients with pulmonary infection and fever.Methods A total of 70 patients were randomly divided into the experimental group and the control group,35 patients in each group.Both groups were given general supportive treatment.The control group was treated with azithromycin and the experimental group was treated with doxycycline.The clinical treatment efficiency,the disappearance time of fever symptoms,the level of pulmonary infection indexes and the occurrence of adverse reactions during medication were compared between the two groups.Results The total effective rate of experimental group was 94.29%,which was significantly higher than that of control group(85.71%).The duration of fever and the time when the body temperature dropped to normal after medication were significantly shorter than those in the control group(P<0.05).WBC count,CRP,procalcitonin and interleukin-6 indexes were significantly improved after doxycycline treatment compared with control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups during treatment(P<0.05).Conclusion The treatment of doxycycline in patients with pulmonary infection with fever can not only rapidly and effectively reduce fever,improve the symptoms of infection,but also significantly reduce the level of infection indicators in blood,with definite efficacy and high safety,which is worthy of extensive clinical promotion.
|
Received: 27 July 2021
|
|
|
|
|
[1] 周芬芬,黄海辉.多西环素可否替代大环内酯类药物用于治疗社区获得性肺炎[J].中国感染与化疗杂志,2014,14(4):279-279. [2] 史发林,丁丽丽,姚新宝,等.基于决策树模型的抗菌药物治疗鲍曼不动杆菌肺部感染经济学评价[J].中国全科医学,2020,23(8):980-984. [3] 吴胜本,郭建峰,马锐 .阿奇霉素治疗孕妇肺炎支原体感染的疗效观察及不良反应监测分析[J].中华医院感染学杂志,2017,27(16):3761-3764. [4] 于亮,王梅.头孢哌酮舒巴坦联合多西环素有效治疗的泛耐药鲍曼不动杆菌特点分析[C].山东:山东病理生理学会危重病医学专业委员会学术大会, 2012. [5] 许官升. 多西环素联合阿奇霉素治疗支原体肺炎疗效研究[J].中国实用医药,2018,13(15):132-133. [6] 王波,陈晓琴 .盐酸多西环素与阿奇霉素在围手术期生殖道支原体感染治疗中的应用效果分析[J].中国性科学,2016,25(11):79-81. [7] 张凤芝. 阿奇霉素联合多西环素治疗成人支原体肺炎效果观察[J].临床合理用药杂志,2018,11(25):66-67. [8] 许鑫松,朱焰,袁琛,等.多西环素在儿童大环内酯类耐药支原体肺炎治疗中的疗效分析[J].浙江临床医学,2017,2(5):2-5. |
[1] |
. [J]. journal1, 2021, 41(6): 54-55. |
|
|
|
|